James Budnick, Ph.D.
About James Budnick, Ph.D.
James Budnick, Ph.D., is a scientist at ATCC in Gaithersburg, Maryland, specializing in molecular microbiology and infectious diseases. He holds a Ph.D. in Biomedical Sciences and Pathobiology from Virginia Tech and has contributed to research and development in his field since 2021.
Work at ATCC
James Budnick has been employed at ATCC as a Scientist since 2021. His role is based in Gaithersburg, Maryland, where he focuses on molecular microbiology. Budnick contributes to the field of infectious diseases through his research and development efforts. He utilizes the ATCC Genome Portal to access reference genomes, which supports his work in bioinformatics and genomic data analysis. His research is directed towards combating infectious diseases and understanding microbial strains.
Education and Expertise
James Budnick holds a Bachelor of Science (BS) in Microbiology from Penn State University, which he completed from 2009 to 2013. He furthered his education at Virginia Tech, where he earned a Doctor of Philosophy (Ph.D.) in Biomedical Sciences and Pathobiology from 2013 to 2019. Additionally, he obtained a Graduate Certificate in Future Professoriate from Virginia Tech between 2013 and 2015. His educational background provides a strong foundation for his expertise in molecular microbiology and infectious diseases.
Background
Before joining ATCC, James Budnick worked at the University of Pittsburgh School of Medicine as a Postdoctoral Fellow from 2019 to 2021. Prior to that, he served as a Graduate Research Assistant at Virginia Tech from 2013 to 2019. His experience in these roles has contributed to his knowledge and skills in research related to infectious diseases and microbial strains.
Research Focus
James Budnick engages in research aimed at combating infectious diseases. His work involves bioinformatics and genomic data analysis, which are critical for understanding the complexities of microbial strains. His contributions to the field are significant, as they support ongoing efforts to address public health challenges associated with infectious diseases.